131 related articles for article (PubMed ID: 3178159)
1. Inhibition of proliferation and induction of differentiation of human myeloid leukemia cells by novel nucleoside analogs.
Honma Y; Ikuta T; Kasukabe T; Hozumi M; Itoh T; Ogura H
Anticancer Res; 1988; 8(4):695-9. PubMed ID: 3178159
[TBL] [Abstract][Full Text] [Related]
2. Effects of novel uracil analogs on proliferation and differentiation of human myeloid leukemia cells.
Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Motoyoshi K
Exp Hematol; 1992 Aug; 20(7):879-85. PubMed ID: 1321051
[TBL] [Abstract][Full Text] [Related]
3. New facts and speculations on human myeloid leukemias.
Breitman TR; Gallo RC
Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
[TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
Honma Y; Kasukabe T; Hozumi M; Tsushima S; Nomura H
Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
[TBL] [Abstract][Full Text] [Related]
5. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate.
Bodner AJ; Ting RC; Gallo RC
J Natl Cancer Inst; 1981 Nov; 67(5):1025-30. PubMed ID: 6946245
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells.
Kohlhepp EA; Condon ME; Hamburger AW
Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521
[TBL] [Abstract][Full Text] [Related]
8. Induction of differentiation of human myeloid leukemia HL-60 cells by novel pyrimidine nucleoside analogs.
Makishima M; Honma Y; Hozumi M; Sampi K; Hattori M; Ishikawa I; Ogura H; Kawahara N; Kanaiwa T; Motoyoshi K
Biochim Biophys Acta; 1991 Aug; 1094(1):1-7. PubMed ID: 1883847
[TBL] [Abstract][Full Text] [Related]
9. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
[TBL] [Abstract][Full Text] [Related]
10. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation.
Cossu G; Kuo AL; Pessano S; Warren L; Cooper RA
Cancer Res; 1982 Feb; 42(2):484-9. PubMed ID: 6948606
[TBL] [Abstract][Full Text] [Related]
11. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
Paukovits JB; Paukovits WR; Laerum OD
Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
13. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the molecular weight and potency of polar compounds which induce the differentiation of HL-60 human promyelocytic leukemia cells.
Langdon SP; Hickman JA
Cancer Res; 1987 Jan; 47(1):140-4. PubMed ID: 3466688
[TBL] [Abstract][Full Text] [Related]
15. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
Lucas DL; Webster HK; Wright DG
J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth but not differentiation of normal and leukemic myeloid cells by methylthioadenosine.
Riscoe MK; Schwamborn J; Ferro AJ; Olson KD; Fitchen JH
Cancer Res; 1987 Jul; 47(14):3830-4. PubMed ID: 3474063
[TBL] [Abstract][Full Text] [Related]
17. Effects of calmodulin antagonists and cytochalasins on proliferation and differentiation of human promyelocytic leukemia cell line HL-60.
Matsui T; Nakao Y; Kobayashi N; Koizumi T; Nakagawa T; Kishihara M; Fujita T
Cancer Res; 1985 Jan; 45(1):311-6. PubMed ID: 3855282
[TBL] [Abstract][Full Text] [Related]
18. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
19. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones.
Ishii Y; Hori Y; Sakai S; Honma Y
Cell Growth Differ; 2002 Jan; 13(1):19-26. PubMed ID: 11801528
[TBL] [Abstract][Full Text] [Related]
20. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
Cancer Res; 1993 May; 53(9):2100-4. PubMed ID: 8481912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
